Donal Geaney

2 results

Perrigo, which bought Irish pharmaceutical group Elan in 2013, wanted the court to quash a 2018 assessment raised against it after a Revenue audit in 2016.

Irish-headquartered drug company Perrigo has lost its High Court action aimed at overturning a €1.64 billion tax assessment. The judgment of Mr Justi(...)

Perrigo claims it had a legitimate expectation that the sale of rights to multiple sclerosis drug Tysabri to Biogen would be treated as trading income not a capital gain

Drug company Perrigo is not a “sacrificial victim” of the Revenue Commissioners arising from a €1.6 billion tax assessment, and it has not been single(...)